The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy
Abstract
CONTEXT: Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare recessive disease characterized by near absence of adipose tissue, resulting in severe dyslipidemia and insulin resistance. In most reported cases, BSCL is due to alterations in either seipin, of unknown function, or 1-acylglycerol-3-phosphate acyltransferase-beta (AGPAT2), which catalyzes the formation of phosphatidic acid. OBJECTIVE: We sought to determine the genetic origin of the unexplained cases of BSCL. We thus sequenced CAV1, encoding caveolin-1, as a candidate gene involved in insulin signaling and lipid homeostasis. CAV1 is a key structural component of plasma membrane caveolae, and Cav1-deficient mice display progressive loss of adipose tissue and insulin resistance. DESIGN: We undertook phenotyping studies and molecular screening of CAV1 in four patients with BSCL with no mutation in the genes encoding either seipin or AGPAT2. RESULTS: A homozygous nonsense mutation (p.Glu38X) was identified in CAV1 in a patient with BSCL born from a consanguineous union. This mutation affects both the alpha- and beta-CAV1 isoforms and ablates CAV1 expression in skin fibroblasts. Detailed magnetic resonance imaging of the proband confirmed near total absence of both sc and visceral adipose tissue, with only vestigial amounts in the dorsal sc regions. In keeping with the lack of adipose tissue, the proband was also severely insulin resistant and dyslipidemic. In addition, the proband had mild hypocalcemia likely due to vitamin D resistance. CONCLUSIONS: These findings identify CAV1 as a new BSCL-related gene and support a critical role for caveolins in human adipocyte function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,454
Role of Caveolae and Caveolins in Health and Disease
Cohen, A. W., Hnasko, R., Schubert, W., & Lisanti, M. P. (2004) · Physiological Reviews · doi:10.1152/physrev.00046.2003 · Cited by 893
Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
Magré, J., Delépine, M., Khallouf, E., Gedde-Dahl, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 756
Self-citationPelkmans, L., & Helenius, A. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30501.x · Cited by 747
Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110970200 · Cited by 583
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
Agarwal, A. K., Arioglu, E., de Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I., & Garg, A. (2002) · Nature Genetics · doi:10.1038/ng880 · Cited by 523
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Williams, T. M., & Lisanti, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2004 · Cited by 511
Cohen, A. W., Razani, B., Wang, X. B., Combs, T. P., Williams, T. M., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00006.2003 · Cited by 351
Lipotoxicity, overnutrition and energy metabolism in aging
Slawik, M., & Vidal-Puig, A. J. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2006.03.004 · Cited by 300
Generalized lipodystrophy, congenital and acquired (lipoatrophy)
Seip, M., & Trygstad, O. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14262.x · Cited by 295
Caveolin-1 Is Essential for Liver Regeneration
Fernández, M. A., Albor, C., Ingelmo-Torres, M., Nixon, S. J., Ferguson, C., Kurzchalia, T., Tebar, F., Enrich, C., Parton, R. G., & Pol, A. (2006) · Science · doi:10.1126/science.1130773 · Cited by 272
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
Van Maldergem, L., Magré, J., Khallouf, T. E., Gedde-Dahl, T., Delépine, M., Trygstad, O., Seemanova, E., Stephenson, T., Albott, C. S., Bonnici, F., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.10.722 · Cited by 250
Self-citationPhenotypic and Genetic Heterogeneity in Congenital Generalized Lipodystrophy
Agarwal, A. K., Simha, V., Oral, E. A., Moran, S. A., Gorden, P., O’Rahilly, S., Zaidi, Z., Gurakan, F., Arslanian, S. A., Klar, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030855 · Cited by 246
Self-citationInvasion activating caveolin-1 mutation in human scirrhous breast cancers.
Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., Hayakawa, T., & Hamaguchi, M. (2001) · PubMed · Cited by 221
Insulin stimulates the tyrosine phosphorylation of caveolin.
Mastick, C. C., Brady, M. J., & Saltiel, A. R. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.6.1523 · Cited by 220
Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine
Unger, R. H. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.014 · Cited by 184
Le Lay, S., Hajduch, E., Lindsay, M. R., Le Lièpvre, X., Thiele, C., Ferré, P., Parton, R. G., Kurzchalia, T., Simons, K., & Dugail, I. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00406.x · Cited by 182
Self-citationSimha, V., & Garg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030835 · Cited by 180
Getting rid of caveolins: Phenotypes of caveolin-deficient animals
Lay, S. L., & Kurzchalia, T. V. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.06.001 · Cited by 152
Genetic disorders of adipose tissue development, differentiation, and death.
Agarwal, A. K., & Garg, A. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115715 · Cited by 150
Cao, G., Yang, G., Timme, T. L., Saika, T., Truong, L. D., Satoh, T., Goltsov, A. A., Park, S. H., Men, T., Kusaka, N., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63920-x · Cited by 95
Gray, S. L., Nora, E. D., Grosse, J., Manieri, M., Stoeger, T., Medina‐Gómez, G., Burling, K., Wattler, S., Russ, A., Yeo, G. S. H., et al. (2006) · Diabetes · doi:10.2337/db06-0389 · Cited by 94
Self-citationPrevalence of Mutations in AGPAT2 Among Human Lipodystrophies
Magré, J., Délepine, M., Maldergem, L. V., Robert, J., Maassen, J. A., Meier, M., Panz, V. R., Kim, C. A., Tubiana‐Rufi, N., Czernichow, P., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1573 · Cited by 84
Self-citationEbihara, K., Kusakabe, T., Masuzaki, H., Kobayashi, N., Tanaka, T., Chusho, H., Miyanaga, F., Miyazawa, T., Hayashi, T., Hosoda, K., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031211 · Cited by 48
Lysophosphatidic acid acyltransferase-?: a novel target for induction of tumour cell apoptosis
Bonham, L., Leung, D. W., White, T., Hollenback, D., Klein, P., Tulinsky, J., Coon, M. E., de Vries, P., & Singer, J. W. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.5.643 · Cited by 42
Role of caveolins in body weight and insulin resistance regulation
Frühbeck, G., López, M., & Diéguez, C. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.04.001 · Cited by 40
Genetic analysis of CAV1 gene in hypertension and metabolic syndrome
Grilo, A., Fernandez, M., Beltrán, M., Ramírez‐Lorca, R., González, M., Royo, J. L., Gutierrez-Tous, R., Morón, F. J., Couto, C., Serrano‐Ríos, M., et al. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-10-0699 · Cited by 25
Cited by
Adipogenesis and metabolic health
Ghaben, A. L., & Scherer, P. E. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0093-z · Cited by 1,395
Carnitine transport and fatty acid oxidation
Longo, N., Frigeni, M., & Pasquali, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.023 · Cited by 996
The role of lipid droplets in metabolic disease in rodents and humans
Greenberg, A. S., Coleman, R. A., Kraemer, F. B., McManaman, J. L., Obin, M. S., Puri, V., Yan, Q.-W., Miyoshi, H., & Mashek, D. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46069 · Cited by 621
Lipid droplet biogenesis and functions in health and disease
Zadoorian, A., Du, X., & Yang, H. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00845-0 · Cited by 617
The roles of vitamin D in skeletal muscle: form, function, and metabolism
Girgis, C. M., Clifton-Bligh, R. J., Hamrick, M. W., Holick, M. F., & Gunton, J. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1012 · Cited by 567
Metadata
- Authors
- Kim, C. A., Delépine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R., Semple, R. K., O’Rahilly, S., Dugail, I., Capeau, J., Lathrop, M., & Magré, J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-04
- Volume
- 93
- Issue
- 4
- Pages
- 1129-1134
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1980143302
- Cited by
- 391
- References
- 28
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.